Cem Bayram

Cem Bayram

Auto-generated profile, based on publicly available information

Cem Bayram

Hacettepe University

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2014 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
NÇNazlı Çalışkan
Nazlı Çalışkan
CBCem Bayram
Cem Bayram
EEEbru Erdal
Ebru Erdal
ZKZeynep Karahaliloğlu
Zeynep Karahaliloğlu
EDEmir Baki Denkbas
Emir Baki Denkbas

1 October 2011 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
FKFiliz Kuralay
Filiz Kuralay
TVTayfun Vural
Tayfun Vural
CBCem Bayram
Cem Bayram
EDEmir Baki Denkbas
Emir Baki Denkbas
SASerdar Abaci
Serdar Abaci

1 September 2016 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
EÇEkin Çelik
Ekin Çelik
CBCem Bayram
Cem Bayram
RARümeysa Akçapınar
Rümeysa Akçapınar
MTMustafa Türk
Mustafa Türk
EDEmir Baki Denkbas
Emir Baki Denkbas

1 November 2011 in Biomacromolecules
Verified
Journal Article
Closed access
ZEZeynep Ekemen
Zeynep Ekemen
HCHong Chang
Hong Chang
Zeeshan AhmadZeeshan Ahmad
Zeeshan Ahmad
CBCem Bayram
Cem Bayram
ZRZimei Rong
Zimei Rong
MEMohan Edirisinghe
Mohan Edirisinghe

20 September 2023 in ACS Applied Materials & Interfaces
Verified
Journal Article
Open access
EAEsra Altun
Esra Altun
CBCem Bayram
Cem Bayram
MGMerve Gultekinoglu
Merve Gultekinoglu
RMRupy Matharu
Rupy Matharu
ADAngelo Delbusso
Angelo Delbusso
Mohan EdirisingheMohan Edirisinghe
Mohan Edirisinghe
Surgical sutures designed to prevent infection are critical in addressing antibiotic-resistant pathogens that cause surgical site infections. Instead of antibiotics, alternative materials such as biocides have been assessed for coating commercially used sutures due to emerging antibiotic resistance concerns worldwide. This study has a new approach to the development of fibrous surgical sutures with the ability to deliver localized antibacterial agents. A new manufacturing process based on pressure spinning was used for the first time in the production of fibrous surgical sutures by physically blending antibacterial triclosan (Tri) agent with poly(lactic-co-glycolic acid) (PLGA) and poly(ethylene oxide) (PEO) polymers. Fibrous surgical sutures with virgin PLGA, virgin PEO, different ratios of PLGA-PEO, and different ratios of Tri-loaded PLGA-PEO fibrous sutures were produced to mimic the FDA- and NICE-approved PLGA-based sutures available in the market and compared for their characteristics. They were also tested simultaneously with commercially available sutures to compare their in vitro biodegradation, antibacterial, drug release, and cytotoxicity properties. After in vitro antibacterial testing for 24 h, sutures having 285 ± 12 μg/mg Tri loading were selected as a model for further testing as they exhibited antibacterial activity against all tested bacteria strains. The selected model of antibacterial fibrous sutures exhibited an initial burst of Tri release within 24 h, followed by a sustained release for the remaining time until the sutures completely degraded within 21 days. The cell viability assay showed that these surgical sutures had no cytotoxic effect on mammalian cells.

1 November 2010 in Applied Surface Science
Verified
Journal Article
Closed access
TVTayfun Vural
Tayfun Vural
FKFiliz Kuralay
Filiz Kuralay
CBCem Bayram
Cem Bayram
SASerdar Abaci
Serdar Abaci
EDEmir Baki Denkbas
Emir Baki Denkbas